Thyro-Tab 0.112 mg recall: CGMP Deviations
Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
Why was Thyro-Tab 0.112 mg recalled?
cGMP Deviations; does not meet in process specification requirements
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #HC31411 and #HE18711
- Product
- Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
- Recalling firm
- Lloyd Inc. of Iowa
- Quantity
- 3,813,645 tablets
- Distribution
- Distribution was nationwide, including Puerto Rico. There was no foreign, military, or government distribution.
- Recall date
- December 12, 2012
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)